The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian

Xin Lai1, Hao Wen1, Yu Li1

  • 1Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.

Insights

Music therapy and acupuncture show promise for treating mild cognitive impairment (MCI), potentially delaying Alzheimer's disease progression. These interventions were found to be more effective than other methods in a comprehensive meta-analysis.

Area of Science:

  • Neurology
  • Gerontology
  • Pharmacology

Background:

  • Mild cognitive impairment (MCI) represents an early stage of Alzheimer's disease (AD).
  • Early interventions aim to slow MCI to AD conversion, but optimal strategies remain debated.
  • This study compares and ranks various interventions for MCI to identify effective treatments for delaying AD.

Approach:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted.
  • Nine interventions were evaluated: cholinesterase inhibitors (ChEIs), ginkgo, nimodipine, Chinese medicine, acupuncture, music therapy, exercise therapy, nutrition therapy, and placebo.
  • The Mini-Mental State Examination (MMSE) and AD Assessment Scale-cognitive subscale (ADAS-cog) were primary and secondary outcomes, respectively.

Key Points:

  • Direct meta-analysis indicated ChEIs, Chinese medicine, exercise, and music therapy improved MMSE scores compared to placebo.
  • For ADAS-cog, ChEIs, acupuncture, Chinese medicine, and exercise therapy demonstrated superiority over placebo.
  • Network meta-analysis ranked music therapy highest for MMSE improvement, followed by acupuncture.
  • Acupuncture ranked highest for ADAS-cog improvement.

Conclusions:

  • Music therapy and acupuncture emerge as leading interventions for managing MCI.
  • These findings offer valuable insights for clinical practice and the development of guidelines for MCI management in AD.
  • Further research may refine optimal intervention strategies for preventing or delaying AD progression.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
667
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
93
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
434